![Brian Kotzin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Kotzin
Directeur/Membre du Conseil chez
BIORA THERAPEUTICS, INC.
Fortune : 826 719 $ au 31/05/2026
Profil
Brian L.
Kotzin is currently Director at Benaroya Research Institute at Virginia Mason, Independent Director at Biora Therapeutics, Inc. since 2019, Non-Executive Director at argenx SE since 2024, Director at Genascence Corp.
since 2022, and Member of the Association of American Physicians and the American Society of Clinical Investigation.
Former positions include Chairman of the Immunological Sciences Study Section at the National Institutes of Health, Director at the American College of Rheumatology, Federation of Clinical Immunology Societies, and Vera Therapeutics, Inc., Director and Head of Clinical Immunology at the Autoimmunity Center of Excellence from 1998 to 2004, Director of the Autoimmunity Centre of Excellence at the University of Colorado Health Sciences Center from 1981 to 2004, Independent Director at Kyverna Therapeutics, Inc. from 2019 to 2024, Independent Director at Rigel Pharmaceuticals, Inc. from 2017 to 2024, Vice President of Global Clinical Development and Head of Inflammation at Amgen, Inc. from 2004 to 2015, Chief of the Rheumatology Section at Veterans Administration Medical Center, Professor at National Jewish Health, Inc., and Chief Medical Officer at Nektar Therapeutics in 2023.
Education includes undergraduate studies at the University of Southern California and a doctorate from Stanford University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/02/2026 | 990 ( 0% ) | 826 719 $ | 31/05/2026 |
Postes actifs de Brian Kotzin
| Sociétés | Poste | Début |
|---|---|---|
| BIORA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/06/2019 |
| ARGENX SE | Directeur/Membre du Conseil | 07/05/2024 |
Genascence Corp.
 Genascence Corp. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company developing gene therapy products for prevalent musculoskeletal diseases | Directeur/Membre du Conseil | 01/01/2022 |
Association of American Physicians
 Association of American Physicians Miscellaneous Commercial ServicesCommercial Services Operates American association of physicians | Corporate Officer/Principal | - |
American Society of Clinical Investigation | Corporate Officer/Principal | - |
Benaroya Research Institute at Virginia Mason
 Benaroya Research Institute at Virginia Mason Miscellaneous Commercial ServicesCommercial Services Operates medical research institute for autoimmune and immune system diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Brian Kotzin
| Sociétés | Poste | Fin |
|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 16/09/2024 |
| KYVERNA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 13/09/2024 |
| NEKTAR THERAPEUTICS | Directeur Technique/Scientifique/R&D | 01/06/2023 |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Brian Kotzin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Rigel Pharmaceuticals, Inc.
 Rigel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which discovers, develops and provides novel small-molecule drugs | Health Technology |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Colorado Health Sciences Center
 University of Colorado Health Sciences Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Veterans Administration Medical Center
 Veterans Administration Medical Center Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
Association of American Physicians
Association of American Physicians Miscellaneous Commercial ServicesCommercial Services Operates American association of physicians | Commercial Services |
American Society of Clinical Investigation | |
American College of Rheumatology
 American College of Rheumatology Miscellaneous Commercial ServicesCommercial Services Operates as an organization for physicians and health professionals | Commercial Services |
argenx SE
 argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
Benaroya Research Institute at Virginia Mason
Benaroya Research Institute at Virginia Mason Miscellaneous Commercial ServicesCommercial Services Operates medical research institute for autoimmune and immune system diseases | Commercial Services |
National Jewish Health, Inc.
 National Jewish Health, Inc. Medical/Nursing ServicesHealth Services Provides treatment of and conducts research in respiratory, immune and allergic disorders | Health Services |
Federation of Clinical Immunology Societies
 Federation of Clinical Immunology Societies Miscellaneous Commercial ServicesCommercial Services Advances interdisciplinary immunology and provides forums for clinical scientists | Commercial Services |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biora Therapeutics, Inc.
 Biora Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing targeted therapies for cancer and autoimmune diseases | Health Technology |
Kyverna Therapeutics, Inc.
 Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
Vera Therapeutics, Inc.
 Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
Genascence Corp.
Genascence Corp. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company developing gene therapy products for prevalent musculoskeletal diseases | Health Technology |
Autoimmunity Center of Excellence |
